Topics

Glioblastoma | Treatment | Off-label Medications | Senicapoc

Home > Publications > Topics > Glioblastoma > Treatment > Off-label Medications > Senicapoc

Eschen JT, Jensen LL, Hausmann D, Lind ANR, Lukacova S, Weischenfeldt J, Lassen U, Westphal M, Winkler F, Simonsen U, Korshoej AR.
SENIPERA Phase 0/1 randomized window-of-opportunity clinical trial of SENIcapoc and PERAmpanel mono- and combination therapy of newly diagnosed glioblastoma: a trial protocol.
BMC Cancer. 2026 Apr 14;26(1):667. doi: 10.1186/s12885-026-15784-y. PMID: 41981510. Trial registration ID: EU-CT: 2025–522605-37–00. ˍ